Trials / Completed
CompletedNCT04567745
Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers
Clinical Validation of an Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Indicating Cognitive Decline
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to provide clinical validation of EyeQuant, a fully automated retinal image analysis system for computation of vascular biomarkers indicative of cognitive disorders, using retinal fundus photographs collected from patients with mild cognitive impairment, Alzheimer's disease, and vascular dementia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Retinal fundus photography | Fundus photographs |
Timeline
- Start date
- 2020-09-29
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2020-09-28
- Last updated
- 2021-11-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04567745. Inclusion in this directory is not an endorsement.